Drug
Androgel (Testosterone Gel)
Androgel (Testosterone Gel) is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
60%(3 trials)
Phase Distribution
Ph phase_3
1
20%
Ph phase_2
3
60%
Ph phase_4
1
20%
Phase Distribution
0
Early Stage
3
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 23 (60.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Short-term Testosterone Replacement in Testicular Cancer Survivors
NCT03339635
completedphase_4
Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy
NCT01201863
completedphase_3
The Testosterone Trials in Older Men
NCT00799617
completedphase_2
Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.
NCT00104572
completedphase_2
Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes
NCT00141492
Clinical Trials (5)
Showing 5 of 5 trials
NCT03339635Phase 2
Short-term Testosterone Replacement in Testicular Cancer Survivors
NCT01201863Phase 4
Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy
NCT00799617Phase 3
The Testosterone Trials in Older Men
NCT00104572Phase 2
Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.
NCT00141492Phase 2
Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5